Earlier today White House Trade and Manufacturing Advisor Peter Navarro discussed an initiative to lunch a new program spearheading new critical supply chains. The goal is to return manufacturing of pharmaceuticals, medicines and equipment back to America.
The White House provided the following outline:
SUPPORTING AMERICAN SUPPLY CHAINS: The Trump Administration is signing a Letter of Interest in support of a deal that will help ensure essential medicines are produced in America.
* The Trump Administration is signing a Letter of Interest supporting a deal to transform Kodak into a pharmaceutical company that can help produce essential medicines in the United States.
* When the deal is final, the CEO of the U.S. International Development Finance Corporation (DFC) will use his delegated Defense Production Act (DPA) loan authority to provide a $765 million loan to launch Kodak Pharmaceuticals, which will create at least 360 jobs.

